Upcoming verified earnings release
BioMarin Pharmaceutical Q4 2026 Earnings Preview
Direct answer
BioMarin Pharmaceutical is scheduled to report Q4 2026 earnings on February 22, 2027.
After the US market closes. The available EPS estimate is 1.2455.
This page will keep the same address and add the reported result when the verified source provides it.
Verified earnings source
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- February 22, 2027
- Reported timing
- After the US market closes
- EPS estimate
- 1.2455
- Reported EPS
- Not provided
Explore related company data
Read the frequently asked questions.
When is BioMarin Pharmaceutical scheduled to report Q4 2026 earnings?
BioMarin Pharmaceutical is scheduled to report on February 22, 2027. The reported timing is after the us market closes.
What is the available EPS estimate for BioMarin Pharmaceutical?
The verified record provides an EPS estimate of 1.2455.
Has BioMarin Pharmaceutical reported the Q4 2026 result?
A reported result has not yet been verified. This same page will show the result after verification.
Which source supports this BioMarin Pharmaceutical earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.